The Data Is In: Reversing Metabolic Disease Is Possible
Metabolic Mind
Role of GLP-1s and medications
Dr. Wolfberg acknowledges GLP-1 benefits and explains Virta prescribes medications when appropriate alongside nutrition first.
What if your diagnosis of type 2 diabetes, high blood pressure, or fatty liver wasn’t a permanent sentence, but a condition that could improve or even reverse through targeted intervention?
In this episode of the Metabolic Mind podcast, Dr. Bret Scher sits down with Dr. Adam Wolfberg, Chief Medical Officer at Virta Health, to explore groundbreaking data that challenges the conventional approach to managing chronic metabolic disease. They dive into Virta’s latest annual report, which highlights powerful clinical and economic outcomes that could reshape the future of medicine.
In this interview, you'll learn:
- Why "reversal" is replacing "management" in the metabolic care conversation
- How Virta’s data shows a 56% reduced risk of heart attack, stroke, or death
- The role of carbohydrate-restricted and ketogenic nutrition in improving metabolic health
- How patients across socioeconomic backgrounds, including those in food deserts, are seeing results
- Where medications like GLP-1 fit into a lifestyle-first model
- What this model means for healthcare costs, medication reduction, and long-term patient outcomes
Virta’s annual report highlights how a shift toward value-based care and personalized, nutrition-driven approaches can drastically improve patient outcomes.
- Check it out here: https://www.virtahealth.com/reversal-report
#MetabolicMind #KetogenicTherapy #MetabolicHealth #FoodAsMedicine
Expert Featured:
Dr. Adam Wolfberg
- Chief Medical Officer at Virta Health
- www.Vitrahealth.com
- LinkedIn.com/in/adamwolfberg
Resources Mentioned:
Virta’s 2025 Annual Report on Metabolic Disease Reversal
Healthcare utilization and cost impact of telehealth-delivered nutrition therapy for type 2 diabetes and obesity: a retrospective claims-based study
Real-World Cardiovascular Outcomes with a Carbohydrate-Reduced Telemedicine Intervention
Reduced Onset of MASLD, MASH, and Advanced Liver Disease in patients who received Individualized Nutrition-Focused Remote Care for Adults with Type 2 Diabetes and Obesity
Effectiveness of telehealth nutritional therapy in preventing chronic kidney disease among adults with type 2 diabetes and obesity: a real-world, retrospective, propensity score–matched cohort study
Free CME Clinician Trainings:
Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein and Dr. Bret Scher with more coming soon.
Our courses have been made FREE by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/
About us:
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
The AI-powered Podcast Player
